Influenza Vaccine for Inflammation

Phase-Based Progress Estimates
Howell Hall, Chapel Hill, NCInflammation+3 MoreInfluenza vaccine - Biological
18 - 35
All Sexes
What conditions do you have?

Study Summary

This trial will look at how the flu vaccine affects social behavior in people by comparing them with a placebo group.

Eligible Conditions
  • Inflammation
  • Psychology and Social Science
  • Social Defeat
  • Social Interaction

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: within approximately 24 hours of treatment

Hour 24
Difference in behaviorally coded social engagement between two social targets
Difference in self-reported social connection between two social targets
Difference in unfair monetary offers accepted

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Influenza Vaccine
1 of 2
Sham Vaccine
1 of 2

Experimental Treatment

Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Influenza Vaccine · Has Placebo Group · Phase 4

Influenza Vaccine
Experimental Group · 1 Intervention: Influenza vaccine · Intervention Types: Biological
Sham Vaccine
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Biological
First Studied
Drug Approval Stage
How many patients have taken this drug
Influenza vaccine
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within approximately 24 hours of treatment

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,381 Previous Clinical Trials
3,929,204 Total Patients Enrolled
23 Trials studying Inflammation
5,239 Patients Enrolled for Inflammation
U.S. National Science FoundationFED
31 Previous Clinical Trials
8,773 Total Patients Enrolled
1 Trials studying Inflammation
200 Patients Enrolled for Inflammation
Keely Muscatell, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Eligibility Criteria

Age 18 - 35 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be between 18 and 35 years old.
You need to bring a friend of the same gender who is willing to participate in the second study session.

Frequently Asked Questions

Is eligibility for this research trial restricted to individuals under 30 years of age?

"The eligibility criteria for this medical trial necessitates that participants must be above the age of consent and below 35 years old." - Anonymous Online Contributor

Unverified Answer

Has the Influenza Vaccine received clearance from the FDA?

"There is a substantial body of evidence which has deemed the influenza vaccine safe, thus it received an overall score of 3." - Anonymous Online Contributor

Unverified Answer

Is enrollment currently available for this research project?

"This medical trial is actively enrolling patients, as indicated by the information available on The study was first posted to this platform on October 17th 2022 and underwent its most recent update on December 8th of the same year." - Anonymous Online Contributor

Unverified Answer

For which types of individuals is this trial most suitable?

"This study requires a cohort of 100 psychologically and sociologically able adults aged eighteen to thirty-five. In addition, these participants must have an individual from the same gender willing to participate in the second trial session." - Anonymous Online Contributor

Unverified Answer

What is the total enrollment capacity of this investigation?

"Affirmative. The information held on suggests that this trial is actively seeking participants, with the original post appearing on October 17th 2022 and a recent update occurring December 8th 2022. A total of 100 patients need to be recruited from one medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.